1 |
Adams NR, DeMayo FJ (2015) The role of steroid hormone receptors in the establishment of pregnancy in rodents. Adv Anat Embryol Cell Biol 216:27-49.
DOI
|
2 |
Bhurke AS, Bagchi IC, Bagchi MK (2016) Progesteroneregulated endometrial factors controlling implantation. Am J Reprod Immunol 75:237-245.
DOI
|
3 |
Chunder N, Mandal S, Basu D, Roy A, Roychoudhury S, Panda CK (2003) Deletion mapping of chromosome 1 in early onset and late onset breast tumors: A comparative study in eastern India. Pathol Res Pract 199:313-321.
DOI
|
4 |
Czyzyk A, Podfigurna A, Genazzani AR, Meczekalski B (2017) The role of progesterone therapy in early pregnancy: From physiological role to therapeutic utility. Gynecol Endocrinol 33:421-424.
DOI
|
5 |
Das SK (2010) Regional development of uterine decidualization: Molecular signaling by Hoxa-10. Mol Reprod Dev 77:387-396.
DOI
|
6 |
Diao H, Xiao S, Zhao F, Ye X (2010) Uterine luminal epithelium-specific proline-rich acidic protein 1 (PRAP1) as a marker for successful embryo implantation. Fertil Steril 94:2808-2811.
DOI
|
7 |
Fox C, Morin S, Jeong JW, Scott RT Jr, Lessey BA (2016) Local and systemic factors and implantation: What is the evidence? Fertil Steril 105:873-884.
DOI
|
8 |
Franco HL, Rubel CA, Large MJ, Wetendorf M, Fernandez-Valdivia R, Jeong JW, Spencer TE, Behringer RR, Lydon JP, Demayo FJ (2012) Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function. FASEB J 26:1218-1227.
DOI
|
9 |
Grandi G, Mueller MD, Bersinger NA, Facchinetti F, McKinnon BD (2017) The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis. Gynecol Endocrinol 33:712-715.
DOI
|
10 |
Guan B, Mao TL, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, Chen E, Jeng YM, Wang TL, Shih IeM (2011a) Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 35:625-632.
DOI
|
11 |
Guan B, Wang TL, Shih IeM (2011b) ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 71:6718-6727.
DOI
|
12 |
Guo X, Zhang Y, Mayakonda A, Madan V, Ding LW, Lin LH, Zia S, Gery S, Tyner JW, Zhou W, Yin D, Lin DC, Koeffler HP (2018) ARID1A and CEBPalpha cooperatively inhibit UCA1 transcription in breast cancer. Oncogene 37:5939-5951.
DOI
|
13 |
Han SJ, O'Malley BW (2014) The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis. Human Reprod Update 20:467-484.
DOI
|
14 |
Jones S, Wang TL, Shih IeM, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA Jr, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N (2010) Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330:228-231.
DOI
|
15 |
Huang BH, Zhuo JL, Leung CH, Lu GD, Liu JJ, Yap CT, Hooi SC (2012) PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage. Cell Death Dis 3:e442.
DOI
|
16 |
Huet-Hudson YM, Andrews GK, Dey SK (1989) Cell typespecific localization of c-myc protein in the mouse uterus: Modulation by steroid hormones and analysis of the periimplantation period. Endocrinology 125:1683-1690.
DOI
|
17 |
Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P (2017) Extracellular matrix in uterine leiomyoma pathogenesis: A potential target for future therapeutics. Human Reprod Update 24:59-85.
|
18 |
Lanemo Myhrinder A, Hellqvist E, Sidorova E, Soderberg A, Baxendale H, Dahle C, Willander K, Tobin G, Backman E, Soderberg O, Rosenquist R, Horkko S, Rosen A (2008) A new perspective: Molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 111:3838-3848.
DOI
|
19 |
Kasik J, Rice E (1997) A novel complementary deoxyribonucleic acid is abundantly and specifically expressed in the uterus during pregnancy. Am J Obstet Gynecol 176:452-456.
DOI
|
20 |
Kim TH, Yoo JY, Wang Z, Lydon JP, Khatri S, Hawkins SM, Leach RE, Fazleabas AT, Young SL, Lessey BA, Ku BJ, Jeong JW (2015) ARID1A is essential for endometrial function during early pregnancy. PLOS Genet 11:e1005537.
DOI
|
21 |
Lee K, Jeong J, Tsai MJ, Tsai S, Lydon JP, DeMayo FJ (2006) Molecular mechanisms involved in progesterone receptor regulation of uterine function. J Steroid Biochem Mol Biol 102:41-50.
DOI
|
22 |
Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW (1995) Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278.
DOI
|
23 |
Mao TL, Shih IeM (2013) The roles of ARID1A in gynecologic cancer. J Gynecol Oncol 24:376-381.
DOI
|
24 |
Marquardt RM, Kim TH, Shin JH, Jeong JW (2019) Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis? Int J Mol Sci 20:3822.
DOI
|
25 |
Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN (2017) Progesterone resistance in endometriosis: Origins, consequences and interventions. Acta Obstet Gynecol Scand 96:623-632.
DOI
|
26 |
Tabibzadeh S (1998) Molecular control of the implantation window. Hum Reprod Update 4:465-471.
DOI
|
27 |
Prior JC (2011) Progesterone for symptomatic perimenopause treatment: Progesterone politics, physiology and potential for perimenopause. Facts Views Vis Obgyn 3:109-120.
|
28 |
Samartzis EP, Noske A, Dedes KJ, Fink D, Imesch P (2013) ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci 14:18824-18849.
DOI
|
29 |
Sze KM, Chu GK, Mak QH, Lee JM, Ng IO (2014) Proline-rich acidic protein 1 (PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma. J Pathol 233:51-60.
DOI
|
30 |
Takeda T, Banno K, Okawa R, Yanokura M, Iijima M, Irie-Kunitomi H, Nakamura K, Iida M, Adachi M, Umene K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D (2016) ARID1A gene mutation in ovarian and endometrial cancers (Review). Oncol Rep 35:607-613.
DOI
|
31 |
Teasley HE, Chang HJ, Kim TH, Ku BJ, Jeong JW (2018) Expression of PIK3IP1 in the murine uterus during early pregnancy. Biochem Biophys Res Commun 495:2553-2558.
DOI
|
32 |
Vasquez YM, DeMayo FJ (2013) Role of nuclear receptors in blastocyst implantation. Semin Cell Dev Biol 24:724-735.
DOI
|
33 |
Wetendorf M, DeMayo FJ (2014) Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus. Int J Dev Biol 58:95-106.
DOI
|
34 |
Wu JN, Roberts CW (2013) ARID1A mutations in cancer: Another epigenetic tumor suppressor? Cancer Discov 3:35-43.
DOI
|
35 |
Zhang J, Wong H, Ramanan S, Cheong D, Leong A, Hooi SC (2003) The proline-rich acidic protein is epigenetically regulated and inhibits growth of cancer cell lines. Cancer Res 63:6658-6665.
|
36 |
Xiong GF, Zhang YS, Han BC, Chen W, Yang Y, Peng JP (2011) Estradiol-regulated proline-rich acid protein 1 is repressed by class I histone deacetylase and functions in peri-implantation mouse uterus. Mol Cell Endocrinol 331:23-33.
DOI
|
37 |
Yoo JY, Yang WS, Lee JH, Kim BG, Broaddus RR, Lim JM, Kim TH, Jeong JW (2017) MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells. Oncogene 37:255-262.
DOI
|